Results 81 to 90 of about 38,447 (226)

Effect of Preemptive Midazolam on Post-Electroconvulsive-Therapy (ECT) Headache, Myalgia, and Nausea and Vomiting

مجله دانشکده پزشکی اصفهان, 2017
Background: Electroconvulsive therapy (ECT) is a controlled electrical stimulus that affects central nervous system and leads to convulsion. Such as every other medical procedure, electroconvulsive therapy has some side effects like headache, myalgia ...
Behzad Nazemroaya, Amirhossein Mohammadi, Jamshid Najafian, Darioush Moradi-Farsani   +3 more
doaj  

The perception of Romanian mental health professionals on electroconvulsive therapy

European Psychiatry
Introduction The journey for the electroconvulsive therapy began in 1938, when convulsive seizures induced by electrical stimulus were used, for the first time, in the therapy of patients diagnosed with Schizophrenia. Over the time, this therapy remains
C. E. Anghel, C. Băcilă
doaj   +1 more source

Clinical dilemma of mood stabilizer augmentation in treatment‐resistant schizophrenia with residual phase: A case report of valproate‐associated hypoglycemia and cytopenia, and subsequent lithium response

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Abstract Background Mood stabilizer augmentation is frequently used in treatment‐resistant schizophrenia despite limited guideline recommendations. Evidence for its efficacy and safety in the residual phase, however, remains insufficient. Case Presentation A 49‐year‐old Japanese woman with treatment‐resistant residual schizophrenia exhibited persistent
Yoshiki Kasagi, Naomichi Okamoto, Reiji Yoshimura   +2 more
wiley   +1 more source

Comparison of the Effect of Ketamine and Sodium Thiopental on Blood Pressure and Heart Rate during Electroconvulsive Therapy in Patients Admitted to the Ward of Psychiatry; A Double-Blind Randomized Clinical Trial

مجله دانشکده پزشکی اصفهان, 2017
Background: Electroconvulsive therapy (ECT) is one the most effective therapies for the treatment of patients with psychotic disorders. Ketamine increases the seizure duration after electroconvulsive therapy.
Behzad Nazemroaya, Amir Shafa, Maryam Khizab   +2 more
doaj  

Recuperação pós-eletroconvulsoterapia: comparação entre propofol, etomidato e tiopental [PDF]

, 2008
OBJECTIVES: To compare post anesthetic time for patient recovery after electroconvulsive therapy, as measured by the post anesthetic Recovery Score of Aldrete and Kroulik, using three different types of hypnotic drugs (propofol, etomidate and thiopental).
BELEGARDE, Iara M T, BUENO, Celso R, FREGNI, Felipe, ROSA, Marina O, ROSA, Moacyr A   +4 more
core   +1 more source

Involuntary Clozapine Treatment: A Systematic Review

Acta Psychiatrica Scandinavica, Volume 153, Issue 6, Page 595-609, June 2026.
ABSTRACT Introduction We aimed to synthesize the information relevant for clinical practice on involuntary clozapine treatment. Methods Articles were identified with MEDLINE, Web of Sciences and PsycINFO search from inception through September 2025 (PROSPERO database registration CRD420251234475).
Hélène Verdoux, Alexis Lepetit, Peter F. J. Schulte   +2 more
wiley   +1 more source

Age-related cognitive effects of ECT and ECT-induced mood improvement in depressive patients [PDF]

, 2006
This explorative study investigated the interaction between electroconvulsive therapy (ECT) treatment-effect, reduced depression, and neuropsychological outcome in relation to age.
Abrams, American Psychiatric Association, Committee on Electroconvulsive Therapy, Beck, Beekman, Benton, Bosboom, Brodaty, Calev, Casey, Deakin, Deijen, Drevets, Fink, Flint, Forsell, Gagne, Gormley, Hamilton, Hammes, Hasse-Sander, Kalb, Kellner, Kujala, Lebowitz, Legendre, Lezak, Luteijn, MacCleod, McCall, Mulsant, Nederlandse Vereniging voor Psychiatrie, O'Connor, Rami-Gonzalez, Rao, Rubin, Saan, Salzman, Sanacora, Schreurs, Serby, Smith, Stinissen, Stroop, Swaab, Tew, Tomac, Van den Broek, Wahlund, Wechsler, Wechsler, Wesson, Wilkinson, Williams, Yoshida, Zervas   +54 more
core   +2 more sources

The Swedish National Quality Register for Repetitive Transcranial Magnetic Stimulation

Acta Psychiatrica Scandinavica, Volume 153, Issue 6, Page 649-655, June 2026.
ABSTRACT Objective Repetitive transcranial magnetic stimulation (rTMS) has been demonstrated to be an effective and well tolerated treatment for depression, and it is being investigated also for other indications. This study presents the Swedish National Quality Register for rTMS (Q‐rTMS).
S. Melker Hagsäter, Axel Nordenskjöld, Pia Nordanskog, Johan Lundberg, Carl Johan Ekman, Fredrik Hieronymus, Robert Bodén   +6 more
wiley   +1 more source

The Dentate Gyrus Grows Throughout Life Despite Turnover of Developmentally‐Born Neurons

Hippocampus, Volume 36, Issue 3, May 2026.
ABSTRACT Adult‐born hippocampal neurons are highly plastic but there remains uncertainty about the magnitude of neurogenesis and its long‐term functional consequences. Theoretical predictions indicate that adult neurogenesis should lead to substantial growth of the dentate gyrus (DG) granule cell population.
Tina Ciric, Shaina P. Cahill, Tyler Lin, Si‐ah Choi, Jason S. Snyder   +4 more
wiley   +1 more source

The Effect of Iclepertin on Hematological Parameters: An Overview of Nonclinical Studies and Clinical Trials in Healthy Volunteers and Patients with Cognitive Impairment Associated with Schizophrenia

The Journal of Clinical Pharmacology, Volume 66, Issue 5, May 2026.
Abstract There are currently no approved pharmacotherapies to treat cognitive impairment associated with schizophrenia (CIAS). Iclepertin (BI 425809) is a selective glycine transporter‐1 (GlyT1) inhibitor that was investigated for the treatment of CIAS.
Peter Nagy, Justin Corey Fowler, Holger Rosenbrock, Wenbo Tang, Eric Fu, Annie Fraser, Holly Dursema, Julia Schlichtiger, Michael Desch, Fredrik Gruenenfelder   +9 more
wiley   +1 more source